Aprea Therapeutics, Inc. (APRE) vs CNS Pharmaceuticals, Inc. (CNSP)
- Aprea Therapeutics, Inc. APRE 0.58 −6.45%
- CNS Pharmaceuticals, Inc. CNSP 4.85 −6.37%
Aprea Therapeutics, Inc. and CNS Pharmaceuticals, Inc. are both Biotechnology companies. Aprea Therapeutics, Inc. and CNS Pharmaceuticals, Inc. are of similar size ($7.9M and $7.8M). Across the 9 metrics below, Aprea Therapeutics, Inc. leads on 7 and CNS Pharmaceuticals, Inc. on 2.
Valuation
Profitability
| Metric | APRE | CNSP | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (47.44%) | (106.62%) | (56.36%) |
| Return on assets | (41.30%) | (91.64%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack